Gema Grahasarana Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Gema Grahasarana Tbk. trades at Rp78 (market cap 124.8B, 225.1K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is the larger of the two by market cap, and Gema Grahasarana Tbk. is more actively traded (225.1K versus 71K). Which is the better fit depends on your goals.
| GEMA | OBAT | |
|---|---|---|
Market Cap | 124.8B | 167.37B |
Volume | 225.1K | 71K |
Lot | 2.25K | 710 |
Turnover | 17.59M | 17.51M |
Average Price | 78.16 | 246.63 |
Value | 17.59M | 17.51M |
Indicative Equilibrium Price | 79 | 246 |
Indicative Equilibrium Volume | 32 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Gema Grahasarana Tbk formerly PT Gema Gerhana Sarana (The Company) was established on December 7th 1984 in Jakarta. The corporate is a member of Vinoti business. The core business is in manufacture, trade and services of interior & furniture. Corporate have 2 subsidiaries: 1. LKS which conduct in industry, trade & service of panel component of furniture & interior. 2. PGM which conduct in industry, trade & construction service of mechanical, electrical for industrial, commercial & industrial.
Read more on GEMA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →